420 with CNW – EU Parliament Votes to Support Medical Cannabis

On Wednesday (February 13), the European Union Parliament passed a resolution that will help to advance research into medical cannabis within the EU. This resolution comes hot on the heels of a recommendation by the World Health Organization (WHO) to reschedule cannabis internationally.

While the resolution passed in the EU Parliament isn’t binding, it provides encouragement to EU member states to increase their citizens’ access to medical marijuana. The resolution also calls on member countries to prioritize research and clinical studies on marijuana.

This resolution passed by the EU Parliament provides yet another voice in support of medical marijuana. The World Health Organization also recommended that cannabis be rescheduled in recognition of its therapeutic potential while also being aware that the drug can be addictive. A final vote is expected in March to cement the position of the UN on the recommendations made by the WHO expert committee that studied the matter at great length.

The EU resolution also goes further to call on member states to set standards for all non-pharmaceutical cannabis products in a bid to protect consumers.

Member states were also called upon to address all the legal, cultural, regulatory and financial barriers that have stood in the way of scientific research on marijuana and its medicinal uses. To put this appeal into context, consider the U.S. federal government’s laws on marijuana. Those laws make it hard for researchers to conduct any meaningful studies since cannabis is federally illegal and isn’t recognized as having any therapeutic value.

Additionally, only one cultivator (based in Mississippi) is mandated to provide all the cannabis needed for any approved research in the U.S. The cannabis from this facility is notorious for its poor quality (if researchers can manage to secure that marijuana in the first place). Such barriers have made the U.S. to lag behind in cannabis research. The EU resolution seeks to fix such problems amongst EU member states.

The members of the European Parliament also agreed that it was necessary to establish case-specific therapies for the medicinal use of cannabis. For example, does someone with chronic pain require the same concentration of THC and CBD (among other ingredients) as another person who wants to use medical cannabis to treat or manage insomnia? Scientific research should be able to answer such questions, according to the EU Parliament.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and Youngevity International, Inc. (NASDAQ: YGYI) welcome the decisions made by the EU Parliament and the World Health organization regarding the medical benefits of marijuana.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Green Growth Brands Set to Open CBD Shops across the US

Green Growth Brands, a cannabis company headquartered in Ohio, has partnered with Simon Property Group to open at least 100 CBD shops in malls across the U.S. Simon Property Group is the biggest owner of malls in the U.S.

John Rulli, the President of Simon Malls, revealed in a press statement that the shopping experience provided by Green Growth Brands was exactly what they are constantly on the lookout for, and that was why they were adding GGB shops in the malls owned by Simon Property Group.

The two entities intend to work together to open a minimum of 108 CBD shops in 2019, and then further expansion will take place in the coming years.

Castleton Square Mall in Indianapolis will have the honor of hosting the first Green Growth Brands CBD shop in March this year with other shops following closely in the coming months.

Green Growth Brands is also having discussions with several other property developers so that a total of 300 CBD shops can be opened during this year. This number includes the 108 shops that will be opened in the malls owned by Simon Property Group.

This partnership between Simon Property Group and Green Growth Brands offers each side unique benefits. For example, Green Growth Brands will have a chance to popularize its CBD wellness products by taking advantage of some of the prominent malls owned by the property group. Such prominent shelf-space will deepen awareness about CBD.

As for Simon Property Group, they will benefit by having a large company as a tenant across the U.S. This is a huge benefit because mall owners have been facing the nightmare of having large clients closing shop or scaling back the number of locations where they operate. A clear example is Sears that went bankrupt.

It is worth noting that the signing into law of the Farm Bill 2018 legalized hemp and the different products that can be got from it, such as cannabidiol (CBD).

However, the U.S. Food and Drug Administration (FDA) still prohibits the addition of CBD to foods and drinks. This may make it hard for restaurants and other businesses to legally sell CBD-infused cocktails and other drinks.

The CBD shops set up by Green Growth Brands can be a way to provide high-quality CBD products so that buyers can make their own CBD drinks if they cannot access them at coffee shops or restaurants.

Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) and TransCanna Holdings Inc. (CSE: TCAN) congratulate Green Growth Brands upon this landmark deal it has finalized with Simon Property Group.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Vertical Integration Offers Profit Potential within Growing Cannabis Industry

CannabisNewsWire Editorial Coverage: As the cannabis industry continues its impressive growth, acquisitions are leading to greater vertical integration.

  • Companies within the cannabis sector are acquiring other organizations to benefit from valuable specialist knowledge and skills.
  • Such deals allow vertically integrated value chains, as have also been applied in industries such as coffee production.
  • This comes amid wider growth in the sector, which is drawing substantial outside investment.

Youngevity International Inc. (NASDAQ: YGYI) (YGYI Profile) is following the vertically integrated model, having recently acquired a company specializing in cannabis processing machinery. Tilray Inc. (NASDAQ: TLRY) is expanding its Canadian production facilities through the acquisition of another grower. Budweiser brewer Anheuser-Busch Inbev (NYSE: BUD) (OTC: BUDFF) has partnered with Tilray to produce cannabis-infused drinks. In addition, tobacco companies are investing in the sector, providing extra funds for companies such as Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON). Specialist companies such as cannabis real estate finance company Innovative Industrial Properties Inc. (NYSE: IIPR) are also looking for…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Consolidation Starts Taking Shape in the US Cannabis Industry

Like any emerging industry, the cannabis industry has reached that time when consolidation starts taking place. Several reasons have made such a step inevitable.

First, way too many businesses rush to get licences in each state that legalizes recreational or medical marijuana. Not all those businesses that open are likely to succeed, so it is only logical that the ones not doing well get gobbled up by those that are having a better run in the market.

Secondly, too many companies in a restricted marketplace trigger a rush to the bottom. The different pricing models adopted to get an edge in the market exert pressure on the profit margins of all the companies involved. Before long, many start falling by the wayside, and the stronger ones acquire those that are failing or struggling.

Thirdly, the risk of oversupply also creates fertile ground for consolidation. Most cannabis businesses are forced to be vertically integrated because of the clash between federal law and state-level laws. Many therefore end up growing cannabis that they are unable sell, and these stockpiles lock up a lot of valuable capital. The entities that command a bigger share of the retail space often end up acquiring those with excess supply.

These forces are already exerting their impact upon the nascent cannabis industry in the U.S. Last year, MedMen Enterprises announced that it was acquiring PharmaCann in a deal worth $682 million. However, this deal still has a few more months before they put ink to paper.

In the meantime, iAnthus Capital Holdings last week closed on a deal to acquire MPX Bioceutical. This acquisition is worth more than $630 million. This makes it the largest marijuana deal in the U.S. so far. The MedMen deal will eclipse it when it is finally concluded, but that is still months away.

With the stroke of a pen, iAnthus Capital Holdings has increased its footprint from just six states to 11 after the acquisition of MPX Bioceutical. The number of licensed dispensaries has also grown from 19 to 63, all without the hassles and costs associated with processing new applications in all those jurisdictions.

The deal also now gives iAnthus a combined grow space of 210,000 square feet. The company targets to expand this to 600,000 square feet so that all the stores/dispensaries can be amply supplied in the coming years.

The cannabis industry, including The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) and The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF) welcome any consolidation that helps to deepen and stabilize the cannabis industry.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – North Dakota Considers Amendments to Improve Access to Medical Marijuana

As North Dakota inches closer to making medical marijuana available to residents, a number of proposals have been brought before the legislature in order to make it easier for patients to access the drug once it becomes available.

One of the most important proposals being considered seeks to include physician assistants among the medical professionals that can certify patients who need medical marijuana cards. The current law only permits advanced practice nurses and physicians to certify patients.

Adding physician assistants to this list would give patients a wider scope of professionals that they can contact for a recommendation.

Another major change that is proposed entails removing the requirement compelling doctors to assert that the patient being recommended will benefit from consuming medical cannabis. This certification requirement has been a major stumbling block in the way of patients who want a recommendation because doctors were uneasy about committing to the efficacy of a drug for a given health condition in the absence of sufficient research backing up the suitability of treating such a condition using medical marijuana.

If the change is adopted, doctors will only be required to state that medical cannabis may help the patient having a qualifying condition. It is hoped that more patients will be able to get recommendations once this change is made.

State statistics show that just about 100 patients had secured medical cannabis cards from October last year when applications started being received. This dismal number was largely due to the reluctance of doctors to certify patients based on the guidelines set in the law passed in 2016.

There is another proposal to include cannabis edibles among the different forms of cannabis that patients can access. This addition is likely to be a welcome one, especially for patients who are uneasy about smoking marijuana. Edibles are more discreet.

While lawmakers are considering proposals to expand the list of qualifying conditions, some advocates are campaigning for a different approach to this matter. They say that it is more sustainable to give the Department of Health the authority to add to the list of qualifying conditions as more research becomes available instead of having to amend the law whenever additional conditions need to be included on that list.

The call of the advocates seems reasonable, because it allows the list of qualifying conditions to grow continuously without the lengthy procedures of the legislative process.

All in all, it is good that the legislature is fine tuning the law so that the beneficiaries (patients) aren’t subjected to any avoidable inconveniences. Sunniva Inc. (CSE: SNN) (OTCQB: SNNVF) and Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTCQX: SPRWF) welcome these changes that will ease access to medical cannabis.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Marijuana Linked to Higher Sperm Concentrations

New research has revealed that men who smoke or have ever smoked cannabis have a higher concentration of sperm when compared to those who have never smoked marijuana. This study was conducted at Massachusetts General Hospital.

The team of researchers, led by a group based at Harvard Chan School of Public Health, based their work on a hypothesis that smoking marijuana would have an adverse effect (poor quality sperm) on the reproductive health of men.

They selected that hypothesis because some previous research seemed to suggest that smoking marijuana was detrimental to male reproductive health. However, those previous studies may have been flawed because they focused on men with drug abuse problems or the research was conducted on mice.

Nevertheless, this research sought to dig deeper into the link between smoking cannabis and sperm health.

To this end, the researchers obtained semen samples from 662 men. These samples (totaling 1,143) were collected for nearly two decades from 2000 to 2017. The men were approximately 36 years old and they were largely white with college degrees.

317 men from that group of participants also provided blood samples to the researchers. These blood samples were analyzed to check for the presence of reproductive hormones.

Additionally, the study participants were asked to fill a questionnaire about their use of marijuana. The questions included whether those men had ever smoked a total of two or more marijuana joints in their lives, and whether they were current cannabis smokers.

55 percent (a total of 365 of that group) of the study subjects admitted that they had ever smoked cannabis. From this number, 11 percent said they still smoked cannabis while 44 percent said they no longer did.

The researchers discovered that the men who smoked or had ever smoked cannabis had approximately 62.7 million sperms in each milliliter of ejaculate. The average sperm concentration for those who said they had never smoked cannabis was 45.4 million in each milliliter of ejaculate.

The World Health Organization puts the threshold for normal sperm concentration at 15million/mL of ejaculate. Interestingly, only 5 percent of the men who smoked cannabis had concentrations lower than this threshold while those who had never smoked had 12 percent of their members registering sperm concentrations that were below this threshold.

Serum testosterone was also higher among men who smoked or had ever smoked cannabis when compared to those who had never done so.

Feiby Nassan, the lead author of this research, warned that their findings should be taken with some caution because the researchers were aware that there is so much that may be going in the bodies of the study participants to explain why the results came out the way they did.

For example, the compounds in cannabis may work with the endocannabinoid system, thereby boosting male fertility.

On the other hand, one can also claim that men who have higher testosterone may be more likely to smoke cannabis since this hormone makes them more likely to indulge in risky behavior.

All in all, the researchers appealed for more research to be conducted on how marijuana affects the reproductive system and the entire body. This is exactly why cannabis industry players like Redfund Capital Corp. (CSE: LOAN) (OTC: PNNRF) (Frankfurt: O3X4) and SinglePoint, Inc. (OTCQB: SING) have been hoping that the U.S. federal government eases its restrictions on cannabis so that American researchers can add onto what researchers elsewhere are doing to increase the available knowledge about cannabis.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – First Marijuana Hearing Scheduled in Congress

In the past, all the bills and measures related to cannabis have been voted out by a Congress that was dominated by Republicans. Now the Democrats have control of the House, and the first hearing on cannabis has been scheduled for tomorrow (February 13).

This particular hearing is slated to consider making legal changes to federal laws so that cannabis businesses can access banking services.

The hearing is titled “Challenges and Solutions: Access to Banking Services for Cannabis-Related Businesses.” This hearing is intended to address the problems that legitimate marijuana-related businesses face when trying to access banking services.

For example, while state-level laws may permit cannabis businesses to open and operate in these jurisdictions, federal laws govern the banking industry and these federal laws don’t allow players in the banking industry to do business with firms involved with cannabis.

Many cannabis businesses have therefore been left with no choice but to operate on a cash basis, and stories abound of businesses that keep their earnings in sacks. In some places, unions and some banks have defied the federal government and decided to take on marijuana businesses as clients.

Even then, only limited banking services are provided by those few banks or unions that decide to accept marijuana businesses as clients. This has constrained the ability of cannabis businesses to obtain credit or even get basic banking services affordably.

It should be remembered that federal banking laws impose strict reporting requirements upon any financial institution that works with a company that is involved in an industry that is regarded as illegal. These reporting requirements inflate the cost of getting banking services.

Congressman Denny Heck, who has been an advocate of the cannabis industry for years, revealed that the hearing plans to address those issues so that the cannabis industry can handle its finances in a way that can easily be tracked by regulators for different purposes, such as ensuring that these businesses are paying their taxes as expected.

This hearing is one of the signs that cannabis may be a major issue during this legislative session. This is a positive step that hasn’t come too soon given the fact that the majority (33) of the states in the union have legalized marijuana, including at least 10 states that now allow recreational marijuana.

It makes sense that federal laws need to be reformed so that there is some kind of alignment between what is happening in the different states and the position of the federal government. Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE: SPR) (FRA: 38G), Sugarmade, Inc. (OTCQB: SGMD) and everyone in the marijuana industry is waiting with bated breath to see what will come of this hearing tomorrow.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Cannabis Cultivators Profit from Growing Legal Market

CannabisNewsWire Editorial Coverage: The growth the legal cannabis market has created has turned cultivation facilities into invaluable assets.

  • The cannabis market is predicted to generate $146 billion in revenues by 2025.
  • Legal changes are accelerating this expansion in the United States and beyond.
  • Cultivation facilities are fundamental to this growth, providing the raw materials for the cannabis industry.

Cannabis Strategic Ventures (OTC: NUGS) (NUGS Profile) recently announced plans to establish a multi-acre cultivation facility in California to meet market demands. Tilray Inc. (NASDAQ: TLRY) is increasing its cultivation space through the acquisition of Natura Naturals Holdings. In addition, the need to equip cultivation facilities is fueling growth for hydroponic suppliers such as GrowGeneration Corp. (OTCQX: GRWG). Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has issued a letter of intent to acquire Whistler in an effort to increase…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Chronic Pain Tops Reasons for Medical Cannabis Use in America

A new study has found that most Americans use medical marijuana in order to ease chronic pain. The study was aimed at finding out the exact reasons why people in the U.S. use medical marijuana, and whether those stated reasons have any scientific basis.

Kevin Boehnke, a researcher at Michigan University’s Chronic Pain and Fatigue Research Center, led the team of researchers who started by analyzing a report that was written in 2017 on the use of medical marijuana. This report was written by the National Academies of Sciences, Engineering and Medicine.

That 2017 report found either conclusive or substantial proof that cannabis eased nausea, muscle spasms, vomiting and chronic pain.

Boehnke and his team also found that in 2016, the number of people who were registered to use medical cannabis was 641,000. This number rose to 814,000 the following year (2017). However, the researchers believe that the actual number of medical cannabis users exceeds the statistics captured in the report they read.

The statistics show that 85.5 percent of medical cannabis card holders were convinced that there was science backing their desire to use medical cannabis for the different qualifying conditions they suffered from. Chronic pain topped the list of qualifying conditions taking up 62 percent of all applications for medical cannabis cards.

The team of researchers wasn’t surprised by their findings regarding chronic pain given that approximately 100 million Americans are estimated to suffer from chronic pain.

Many of those medical cannabis users, such as Brandian Smith from Illinois, say that they resorted to medical cannabis because it worked better than the prescription opiates that they had been using previously.

This anecdotal evidence from actual medical cannabis users, together with the scientific studies that prove that medical marijuana can combat chronic pain, may offer a ray of hope in the fight against the opioid crisis in the U.S.

Currently, 33 states have legalized the use of medical marijuana. 10 states, as well as the District of Columbia, have decriminalized adult-use marijuana. These 33 states can potentially start a wave rolling back the opioid problem if this matter is given more attention.

For now, the federal government remains adamant that marijuana hasn’t been proved to have any medical use, so it remains a Schedule 1 substance. Boehnke and his team of researchers feel strongly that their findings make a case for changing the federal government’s position so that cannabis can be integrated in the medical system of the country. Phivida Holdings Inc. (CSE: VIDA) (OTCQX: PHVAF) and Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) couldn’t agree more with Kevin Boehnke’s conclusions.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Oregon Lawmaker Introduces Bill to Protect Cannabis Users Who Need Organ Transplants

A Portland lawmaker, Rep. Rob Nosse, has introduced House Bill 2687 geared at ensuring that medical cannabis users aren’t removed from the waiting list for organ transplants in the State.

This Bill will prevent medical practitioners from recommending that medical cannabis users be removed from the waiting list for organ transplants managed by different organizations in the State, such as United Network for Organ Sharing.

Approximately 850 people in Oregon are waiting to get a suitable match for an organ transplant, yet just 340 transplant surgeries were performed in the state last year.

Many of those people on the waiting list resort to medical marijuana in order to alleviate their severe symptoms.

In response to the bill introduced by Nosse, many of the transplant centers in Oregon denied that they turn away anyone who tests positive for marijuana.

Piseth Pich, one of Legacy Health’s community relations officials in Portland, revealed that their center assesses patients based on a number of requirements, including drugs tests, as a way to understand that patient’s overall health condition before that person is declared suitable for a transplant.

Pich added that it is hard to put a number on how many people who have been found unsuitable just by looking at only factor since suitability is determined on the basis of multiple factors.

It is common for someone to wait for years before ever finding a suitable organ, and even after the transplant process many people’s bodies reject the donated organ as foreign.

Representatives of the different transplant centers have expressed reservations about Nosse’s bill. For example, they say that the bill wants to make it legal for the transplant centers to disregard a factor that can have a bearing on the likely success of a transplant procedure.

While appearing before the House Committee on Health Care, Nosse presented a woman, Robin Socherman, whose situation can be regarded as a case study of what medical marijuana users go through when they need an organ transplant.

Robin Socherman is interested in donating a kidney to her husband, but he was removed from the waiting list after he tested positive for marijuana. Her husband, Jake Socherman, started using medical marijuana about six years ago to combat back pain. This pain has since been linked to his enlarged kidneys.

The transplant center advised Jake to stop using medical cannabis in order to be eligible for an organ transplant. However, he resumed using marijuana after his symptoms got worse, and the transplant center promptly removed him from the waiting list.

Nosse told the committee that cases like that of Socherman prompted him to introduce the bill so that medical cannabis users aren’t victimized when they need an organ. MustGrow Biologics Corp., Net Element (NASDAQ: NETE) and the entire marijuana industry agree that people like Jake Socherman need to be given all the legal protections that they can get so that their health doesn’t suffer just because they are consuming a legal product.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com